These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7205213)

  • 1. Reversed-phase high-performance liquid chromatographic analysis of liothyronine sodium and levothyroxine sodium in tablet formulations: preliminary studies on dissolution and content uniformity.
    Rapaka RS; Knight PW; Prasad VK
    J Pharm Sci; 1981 Feb; 70(2):131-4. PubMed ID: 7205213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The separation and determination of liothyronine and levothyroxine in tablets by reversed-phase high performance liquid chromatography.
    Smith DJ; Biesemeyer M; Yaciw C
    J Chromatogr Sci; 1981 Feb; 19(2):72-8. PubMed ID: 7228964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic assay for sodium levothyroxine in tablet formulations: content uniformity applications.
    Garnick RL; Burt GF; Long DA; Bastian JW; Aldred JP
    J Pharm Sci; 1984 Jan; 73(1):75-7. PubMed ID: 6694088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability-indicating assay, dissolution, and content uniformity of sodium levothyroxine in tablets.
    Richheimer SL; Amer TM
    J Pharm Sci; 1983 Nov; 72(11):1349-51. PubMed ID: 6644603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of liothyronine and levothyroxine in thyroid preparations by liquid chromatography.
    Richheimer SL; Jensen CB
    J Pharm Sci; 1986 Feb; 75(2):215-7. PubMed ID: 3514844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse phase high pressure liquid chromatographic determination of some iodoamino acid contaminants in sodium liothyronine or sodium levothyroxine.
    Smith DJ; Graham JH
    J Assoc Off Anal Chem; 1979 Jul; 62(4):818-21. PubMed ID: 500533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of sodium levothyroxine in bulk, tablet, and injection formulations by high-performance liquid chromatography.
    Brower JF; Toler DY; Reepmeyer JC
    J Pharm Sci; 1984 Sep; 73(9):1315-7. PubMed ID: 6491963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of a validated HPLC method for the analysis of dissolution samples of levothyroxine sodium drug products.
    Collier JW; Shah RB; Bryant AR; Habib MJ; Khan MA; Faustino PJ
    J Pharm Biomed Anal; 2011 Feb; 54(3):433-8. PubMed ID: 20947276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of sodium levothyroxine or sodium liothyronine in tablets.
    Graham JH; Banes D; Biesemeyer ME; Nadkarni A
    J Pharm Sci; 1974 May; 63(5):763-6. PubMed ID: 4830000
    [No Abstract]   [Full Text] [Related]  

  • 10. Simple high-performance liquid chromatographic assay for norethindrone--mestranol in combination tablets.
    Sundaresan GM; Goehl TJ; Prasad VK
    J Pharm Sci; 1981 Jun; 70(6):702-4. PubMed ID: 7252827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are multisource levothyroxine sodium tablets marketed in Egypt interchangeable?
    Abou-Taleb BA; Bondok M; Nounou MI; Khalafallah N; Khalil S
    Ann Endocrinol (Paris); 2018 Feb; 79(1):23-29. PubMed ID: 29289332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of batch age on potency and dissolution of levothyroxine sodium tablets: impact of BP and USP monograph differences on dissolution results.
    Abou-Taleb BA; Nounou MI; Khalafallah N; Khalil S
    Drug Dev Ind Pharm; 2018 Nov; 44(11):1762-1769. PubMed ID: 29973090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential pulse polarographic analysis of thyroid hormone: determination of iodine, thyroxine, and liothyronine.
    Holak W; Shostak D
    J Pharm Sci; 1979 Mar; 68(3):338-42. PubMed ID: 423124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and semiquantitative estimation of thyroxine and diiodothyronine in liothyronine sodium.
    Cieri UR; Illuminati JC
    J Assoc Off Anal Chem; 1977 May; 60(3):628-34. PubMed ID: 192708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liothyronine and levothyroxine in Armour thyroid.
    Blumberg KR; Mayer WJ; Parikh DK; Schnell LA
    J Pharm Sci; 1987 Apr; 76(4):346-7. PubMed ID: 3598896
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of thyroid hormones in pharmaceutical preparations, after derivatization with 9-anthroylnitrile, by high-performance liquid chromatography with fluorescence detection.
    Takahashi M; Nagashima M; Shigeoka S; Kamimura H; Kamata K
    J Chromatogr A; 2002 Jun; 958(1-2):299-303. PubMed ID: 12134828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new universal high-performance liquid chromatographic method for determination of 1,4-benzodiazepines as bulk drugs and in pharmaceutical formulations.
    Kazemifard AG; Javadzadeh N; Gholami K
    Acta Pol Pharm; 2008; 65(2):179-86. PubMed ID: 18666423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic analysis of nadolol and bendroflumethiazide combination tablet formulations.
    Perlman S; Szyper M; Kirschbaum JJ
    J Pharm Sci; 1984 Feb; 73(2):259-61. PubMed ID: 6707897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of minoxidil in bulk drug and pharmaceutical formulations by ion-pairing high-performance liquid chromatography.
    Asmus PA; Landis JB; Grant ME; Havel HA
    J Pharm Sci; 1984 Sep; 73(9):1290-3. PubMed ID: 6491953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
    Svirskis D; Lin SW; Brown H; Sangaroomthong A; Shin D; Wang Z; Xu H; Dean R; Vareed P; Jensen M; Wu Z
    Int J Pharm Compd; 2018; 22(2):164-171. PubMed ID: 29877863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.